Glutamate receptors in microglia

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 6, 2013, Pages 773-784

  Murugan, Madhuvika ^a   Ling, Eng Ang ^a   Kaur, Charanjit ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

AMPA receptors; Cytokines; Free radical production; Glutamate receptors; Metabotropic receptors; Microglia; NMDA receptors

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7, 8 METHYLENEDIOXY 5H 2, 3 BENZODIAZEPINE; 1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 CYANO 7 NITRO 2, 3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO [F] QUINOXALINE 2, 3 DIONE; 6, 7 DINITRO 2, 3 QUINOXALINEDIONE; AMPA RECEPTOR; DIZOCILPINE; FREE RADICAL; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 4; INTERLEUKIN 1BETA; KAINIC ACID RECEPTOR; LIPOPOLYSACCHARIDE; MEMANTINE; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; N ACETYLASPARTYLGLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; QUINOLINIC ACID; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CALCIUM SIGNALING; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; MICROGLIA; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE HOMOLOGY; SYNAPTIC TRANSMISSION; WESTERN BLOTTING;

ANIMALS; CYTOKINES; FREE RADICALS; GLUTAMIC ACID; HUMANS; MICROGLIA; RECEPTORS, GLUTAMATE;

EID: 84888043489     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/18715273113126660174     Document Type: Review

References (125)

1. Ozawa, S.; Kamiya, H.; Tsuzuki, K. Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol., 1998, 54, 581-618.
2. Teichberg, V.I. Glial glutamate receptors: likely actors in brain signaling. FASEB J., 1991, 5, 3086-3091.
3. Steinhäuser, C.; Gallo, V. News on glutamate receptors in glial cells. Trends Neurosci., 1996, 19, 339-345.
4. Bowman, C.L.; Kimelberg, H.K. Excitatory amino acids directly depolarize rat brain astrocytes in primary culture. Nature, 1984, 311, 656-659.
5. Sontheimer, H.; Kettenmann, H.; Backus, K.H.; Schachner, M. Glutamate opens Na+/K+ channels in cultured astrocytes. Glia, 1988, 1, 328-336.
6. Gallo, V.; Giovannini, C.; Suergiu, R.; Levi, G. Expression of excitatory amino acid receptors by cerebellar cells of the type-2 astrocyte cell lineage. J. Neurochem., 1989, 52, 1-9.
7. Usowicz, M.M.; Gallo, V.; Cull-Candy, S.G. Multiple conductance channels in type-2 cerebellar astrocytes activated by excitatory amino acids. Nature, 1989, 339, 380-383.
8. Usowicz, M.M.; Gallo, V.; Cull-Candy, S.G. Multiple conductance channels in type-2 cerebellar astrocytes activated by excitatory amino acids. Nature, 1989, 339, 380-383.
9. Cornell-Bell, A.H.; Finkbeiner, S.M.; Cooper, M.S.; Smith, S.J. Glutamate induces calcium waves in cultured astrocytes: longrange glial signaling. Science, 1990, 247, 470-473.
10. Bezzi, P.; Carmignoto, G.; Pasti, L.; Vesce, S.; Rossi, D.; Rizzini, B.L.; Pozzan, T.; Volterra, A. Prostaglandins stimulate calciumdependent glutamate release in astrocytes. Nature, 1998, 391, 281-285.
11. Queiroz, G.; Gebicke-Haerter, P.J.; Schobert, A.; Starke, K.; von Kügelgen, I. Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation. Neuroscience, 1997, 78, 1203-1208.
12. Follett, P.L.; Deng, W.; Dai, W.; Talos, D.M.; Massillon, L.J.; Rosenberg, P.A.; Volpe, J.J.; Jensen, F.E. Glutamate receptormediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J. Neurosci., 2004, 24, 4412-4420.
13. Salter, M.G.; Fern, R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature, 2005, 438, 1167-1171.
14. Deng, W.; Wang, H.; Rosenberg, P.A.; Volpe, J.J.; Jensen, F.E. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc. Natl. Acad. Sci. USA, 2004, 101, 7751-7756.
15. Choi, D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1988, 1, 623-634.
16. Lau, A.; Tymianski, M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch., 2010, 460, 525-542.
17. Barger, S.W.; Basile, A.S. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J. Neurochem., 2001, 76, 846-854.
18. Barger, S.W.; Goodwin, M.E.; Porter, M.M.; Beggs, M.L. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J. Neurochem., 2007, 101, 1205-1213.
19. Piani, D.; Fontana, A. Involvement of the cystine transport system xc-in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J. Immunol., 1994, 152, 3578-3585.
20. Matute, C.; Domercq, M.; Sánchez-Gómez, M.V. Glutamatemediated glial injury: mechanisms and clinical importance. Glia, 2006, 53, 212-224.
21. Curtis, D.R.; Phillis, J.W.; Watkins, J.C. The chemical excitation of spinal neurones by certain acidic amino acids. J. Physiol., 1960, 150, 656-682.
22. Hayashi, T. A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics. Jpn J. Physiol., 1952, 3, 46-64.
23. Nakanishi, S. The molecular diversity of glutamate receptors. Prog. Clin. Biol. Res., 1994, 390, 85-98.
24. Niswender, C.M.; Conn, P.J. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu. Rev. Pharmacol. Toxicol., 2010, 50, 295-322.
25. Rossi, D.; Martorana, F.; Brambilla, L. Implications of gliotransmission for the pharmacotherapy of CNS disorders. CNS Drugs, 2011, 25, 641-658.
26. Harata, N.; Katayama, J.; Akaike, N. Excitatory amino acid responses in relay neurons of the rat lateral geniculate nucleus. Neuroscience, 1999, 89, 109-125.
27. Profaci, C.P.; Krolikowski, K.A.; Olszewski, R.T.; Neale, J.H. Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia. Psychopharmacology, 2011, 216, 235-243.
28. Passani, L.; Elkabes, S.; Coyle, J.T. Evidence for the presence of N-acetylaspartylglutamate in cultured oligodendrocytes and LPS activated microglia. Brain Res., 1998, 794, 143-145.
29. Johnson, J.W.; Ascher, P. Equilibrium and kinetic study of glycine action on the N-methyl-D-aspartate receptor in cultured mouse brain neurons. J. Physiol., 1992, 455, 339-365.
30. Van den Eynden, J.; Notelaers, K.; Brône, B.; Janssen, D.; Nelissen, K.; Sahebali, S.; Smolders, I.; Hellings, N.; Steels, P.; Rigo, J.M. Glycine enhances microglial intracellular calcium signaling. A role for sodium-coupled neutral amino acid transporters. Pflugers Arch., 2011, 461, 481-491.
31. Tanaka, J.; Toku, K.; Matsuda, S.; Sudo, S.; Fujita, H.; Sakanaka, M.; Maeda, N. Induction of resting microglia in culture medium devoid of glycine and serine. Glia, 1998, 24, 198-215.
32. Beal, M.F.; Kowall, N.W.; Ellison, D.W.; Mazurek, M.F.; Swartz, K.J.; Martin, J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature, 1986, 321, 168-171.
33. Schwarcz, R.; Köhler, C. Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci. Lett., 1983, 38, 85-90.
34. Espey, M.G.; Chernyshev, O.N.; Reinhard, J.F.; Namboodiri, M.A.; Colton, C.A. Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport, 1997, 8, 431-434.
35. Heyes, M.P.; Achim, C.L.; Wiley, C.A.; Major, E.O.; Saito, K.; Markey, S.P. Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem. J., 1996, 320(Pt 2), 595-597.
36. Steiner, J.; Walter, M.; Gos, T.; Guillemin, G.J.; Bernstein, H.G.; Sarnyai, Z.; Mawrin, C.; Brisch, R.; Bielau, H.; Meyer, zu Schwabedissen, L.; Bogerts, B.; Myint, A.M. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J. Neuroinflammation, 2011, 8, 94.
37. Thomsen, C.; Suzdak, P.D. Serine-O-phosphate has affinity for type IV, but not type I, metabotropic glutamate receptor. Neuroreport, 1993, 4, 1099-1101.
38. Bailey, T.J.; Fossum, S.L.; Fimbel, S.M.; Montgomery, J.E.; Hyde, D.R. The inhibitor of phagocytosis, O-phospho-L-serine, suppresses Müller glia proliferation and cone cell regeneration in the light-damaged zebrafish retina. Exp. Eye Res., 2010, 91, 601-612.
39. Noda, M.; Nakanishi, H.; Nabekura, J.; Akaike, N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J. Neurosci, 2000, 20, 251-258.
40. Hagino, Y.; Kariura, Y.; Manago, Y.; Amano, T.; Wang, B.; Sekiguchi, M.; Nishikawa, K.; Aoki, S.; Wada, K.; Noda, M. Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia. Glia, 2004, 47, 68-77.
41. Liu, G.J.; Kalous, A.; Werry, E.L.; Bennett, M.R. Purine release from spinal cord microglia after elevation of calcium by glutamate. Mol. Pharmacol., 2006, 70, 851-859.
42. Sivakumar, V.; Ling, E.A.; Lu, J.; Kaur, C. Role of glutamate and its receptors and insulin-like growth factors in hypoxia induced periventricular white matter injury. Glia, 2010, 58, 507-523.
43. Fontainhas, A.M.; Wang, M.; Liang, K.J.; Chen, S.; Mettu, P.; Damani, M.; Fariss, R.N.; Li, W.; Wong, W.T. Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission. PloS ONE, 2011, 6, e15973.
44. Drouin-Ouellet, J.; Brownell, A.L.; Saint-Pierre, M.; Fasano, C.; Emond, V.; Trudeau, L.E.; Lévesque, D.; Cicchetti, F. Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions. Glia, 2011, 59, 188-199.
45. Verkhratsky, A.; Kirchhoff, F. Glutamate-mediated neuronal-glial transmission. J. Anat., 2007, 210, 651-660.
46. Streit, W.J.; Morioka, T.; Kalehua, A.N. MK-801 prevents microglial reaction in rat hippocampus after forebrain ischemia. Neuroreport, 1992, 3, 146-148.
47. Acarin, L.; González, B.; Castellano, B.; Castro, A.J. Microglial response to N-methyl-D-aspartate-mediated excitotoxicity in the immature rat brain. J. Comp. Neurol., 1996, 367, 361-374.
48. Thomas, D.M.; Kuhn, D.M. MK-801 and dextromethorphan block microglial activation and protect against methamphetamineinduced neurotoxicity. Brain Res., 2005, 1050, 190-198.
49. Boje, K.M.; Arora, P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res., 1992, 587, 250-256.
50. Murugan, M.; Sivakumar, V.; Lu, J.; Ling, E.A.; Kaur, C. Expression of N-methyl D-aspartate receptor subunits in amoeboid microglia mediates production of nitric oxide via NF-κB signaling pathway and oligodendrocyte cell death in hypoxic postnatal rats. Glia, 2011, 59, 521-539.
51. Gottlieb, M.; Matute, C. Expression of ionotropic glutamate receptor subunits in glial cells of the hippocampal CA1 area following transient forebrain ischemia. J. Cereb. Blood Flow Metab., 1997, 17, 290-300.
52. Tahraoui, S.L.; Marret, S.; Bodénant, C.; Leroux, P.; Dommergues, M.A.; Evrard, P.; Gressens, P. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol., 2001, 11, 56-71.
53. Biber, K.; Laurie, D.J.; Berthele, A.; Sommer, B.; Tölle, T.R.; Gebicke-Härter, P.J.; van Calker, D.; Boddeke, H.W. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. J. Neurochem., 1999, 72, 1671-1680.
54. Geurts, J.J.G.; Wolswijk, G.; Bö, L.; van der Valk, P.; Polman, C.H.; Troost, D.; Aronica, E. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain, 2003, 126, 1755-1766.
55. Byrnes, K.R.; Stoica, B.; Loane, D.J.; Riccio, A.; Davis, M.I.; Faden, A.I. Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia, 2009, 57, 550-560.
56. Farso, M.C.; O'Shea, R.D.; Beart, P.M. Evidence group I mGluR drugs modulate the activation profile of lipopolysaccharideexposed microglia in culture. Neurochem. Res., 2009, 34, 1721-1728.
57. Loane, D.J.; Stoica, B.A.; Pajoohesh-Ganji.; Byrnes, K.R.; Faden, A.I. Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase. J. Biol. Chem., 2009, 284, 15629-15639.
58. Taylor, D.L.; Diemel, L.T.; Cuzner, M.L.; Pocock, J.M. Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease. J. Neurochem., 2002, 82, 1179-1191.
59. Taylor, D.L.; Jones, F.; Kubota, E.S.F.C.S.; Pocock, J.M. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J. Neurosci., 2005, 25, 2952-2964.
60. Pinteaux-Jones, F.; Sevastou, I.G.; Fry, V.A.H.; Heales, S.; Baker, D.; Pocock, J.M. Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. J. Neurochem., 2008, 106, 442-454.
61. Berger, J.V.; Dumont, A.O.; Focant, M.C.; Vergouts, M.; Sternotte, A.; Calas, A.G.; Goursaud, S.; Hermans, E. Opposite regulation of metabotropic glutamate receptor 3 and metabotropic glutamate receptor 5 by inflammatory stimuli in cultured microglia and astrocytes. Neuroscience, 2012, 205, 29-38.
62. Matarredona, E.R.; Santiago, M.; Venero, J.L.; Cano, J.; Machado, A. Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+sssinduced neurotoxicity along with brain-derived neurotrophic factor induction. J. Neurochem., 2001, 76(2), 351-360.
63. Chan, H.; Paur, H.; Vernon, A.C.; Zabarsky, V.; Datla, K.P.; Croucher, M.J.; Dexter, D.T. Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease. Parkinsons Dis., 2010, 201, 1-12
64. McMullan, S.M.; Phanavanh, B.; Li, G.G.; Barger, S.W. Metabotropic glutamate receptors inhibit microglial glutamate release. ASN Neurol., 2013, in press.
65. Kaushal, V.; Schlichter, L.C. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci., 2008, 28, 2221-2230.
66. Venero, J.L.; Santiago, M.; Tomás-Camardiel, M.; Matarredona, E.R.; Cano, J.; Machado, A. DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury. Neuroscience, 2002, 113(4), 857-869.
67. Piers, T.M.; Heales, S.J.; Pocock, J.M. Positive allosteric modulation of metabotropic glutamate receptor 5 down-regulates fibrinogen-activated microglia providing neuronal protection. Neurosci. Lett., 2011, 505, 140-145.
68. Taylor, D.L.; Diemel, L.T.; Pocock, J.M. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J. Neurosci., 2003, 23, 2150-2160.
69. Takeuchi, H.; Jin, S.; Wang, J.; Zhang, G.; Kawanokuchi, J.; Kuno, R.; Sonobe, Y.; Mizuno, T.; Suzumura, A. Tumor necrosis factoralpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem., 2006, 281, 21362-21368.
70. Wake, H.; Moorhouse, A.J.; Jinno, S.; Kohsaka, S.; Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci., 2009, 29, 3974-3980.
71. Tremblay, M. È.; Lowery, R.L.; Majewska, A.K. Microglial interactions with synapses are modulated by visual experience. PLoS Biol., 2010, 8, e1000527.
72. Achour, B.S.; Pascual, O. Glia: the many ways to modulate synaptic plasticity. Neurochem. Int., 2010, 57, 440-445.
73. Pascual, O.; Achour, B.S.; Rostaing, P.; Triller, A.; Bessis, A. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc. Natl. Acad. Sci. USA, 2012, 109, E197-E205.
74. Möller, T. Calcium signaling in microglial cells. Glia, 2002, 40, 184-194.
75. Nakanishi, S.; Nakajima, Y.; Masu, M.; Ueda, Y.; Nakahara, K.; Watanabe, D.; Yamaguchi, S.; Kawabata, S.; Okada, M. Glutamate receptors: brain function and signal transduction. Brain Res. Brain Res. Rev., 1998, 26, 230-235.
76. Whittemore, E.R.; Korotzer, A.R.; Etebari, A.; Cotman, C.W. Carbachol increases intracellular free calcium in cultured rat microglia. Brain Res., 1993, 621, 59-64.
77. Färber, K.; Kettenmann, H. Functional role of calcium signals for microglial function. Glia, 2006, 54, 656-665.
78. Hoffmann, A.; Kann, O.; Ohlemeyer, C.; Hanisch, U.K.; Kettenmann, H. Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function. J. Neurosci., 2003, 23, 4410-4419.
79. Veerhuis, R.; Boshuizen, R.S.; Morbin, M.; Mazzoleni, G.; Hoozemans, J.J.M.; Langedijk, J.P.M.; Tagliavini, F.; Langeveld, J.P.M.; Eikelenboom, P. Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q. Neurobiol. Dis., 2005, 19, 273-282.
80. McLarnon, J.G.; Choi, H.B.; Lue, L.F.; Walker, D.G.; Kim, S.U. Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients. J. Neurosci. Res., 2005, 81, 426-435.
81. Eichhoff, G.; Brawek, B.; Garaschuk, O. Microglial calcium signal acts as a rapid sensor of single neuron damage in vivo. Biochim. Biophys. Acta, 2011, 1813, 1014-1024.
82. Lawson, L.J.; Perry, V.H.; Dri, P.; Gordon, S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience, 1990, 39, 151-170.
83. Ling, E.A.; Ng, Y.K.; Wu, C.H.; Kaur, C. Microglia: its development and role as a neuropathology sensor. Prog. Brain Res., 2001, 132, 61-79.
84. Dheen, S.T.; Kaur, C.; Ling, E.A. Microglial activation and its implications in the brain diseases. Curr. Med. Chem., 2007, 14, 1189-1197.
85. Ling, E.A.; Wong, W.C. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia, 1993, 7, 9-18.
86. Christensen, R.N.; Ha, B.K.; Sun, F.; Bresnahan, J.C.; Beattie, M.S. Kainate induces rapid redistribution of the actin cytoskeleton in ameboid microglia. J. Neurosci. Res., 2006, 84, 170-181.
87. Nimmerjahn, A.; Kirchhoff, F.; Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science, 2005, 308, 1314-1318.
88. Liu, G.J.; Nagarajah, R.; Banati, R.B.; Bennett, M.R. Glutamate induces directed chemotaxis of microglia. Eur. J. Neurosci., 2009, 29, 1108-1118.
89. Hanisch, U. Microglia as a source and target of cytokines. Glia, 2002, 40, 140-155.
90. Werry, E.L.; Liu, G.J.; Lovelace, M.D.; Nagarajah, R.; Hickie, I.B.; Bennett, M.R. Lipopolysaccharide-stimulated interleukin-10 release from neonatal spinal cord microglia is potentiated by glutamate. Neuroscience, 2011, 175, 93-103.
91. Zhao, M.L.; Liu, J.S.; He, D.; Dickson, D.W. Lee, S.C. Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain. Brain Res., 1998, 813, 402-405.
92. You, Y.; Kaur, C. Expression of induced nitric oxide synthase in amoeboid microglia in postnatal rats following an exposure to hypoxia. Neurosci. Lett., 2000, 279, 101-104.
93. Tran, E.H.; Hardin-Pouzet, H.; Verge, G.; Owens, T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol., 1997, 74, 121-129.
94. Colton, C.A.; Chernyshev, O.N.; Gilbert, D.L.; Vitek, M.P. Microglial contribution to oxidative stress in Alzheimer's disease. Ann. NY Acad. Sci., 2000, 899, 292-307.
95. Stagi, M.; Dittrich, P.S.; Frank, N.; Iliev, A.I.; Schwille, P.; Neumann, H. Breakdown of axonal synaptic vesicle precursor transport by microglial nitric oxide. J. Neurosci., 2005, 25, 352-362.
96. Bal-Price, A.; Brown, G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci., 2001, 21, 6480-6491.
97. Peterson, L.J.; Flood, P.M. Oxidative stress and microglial cells in Parkinson's disease. Mediators Inflamm., 2012, 2012, 401264.
98. Jordan, M.L.; Rominski, B.; Jaquins-Gerstl, A.; Geller, D.; Hoffman, R.A. Regulation of inducible nitric oxide production by intracellular calcium. Surgery, 1995, 118, 138-145.
99. Infanger, D.W.; Sharma, R.V.; Davisson, R.L. NADPH oxidases of the brain: distribution, regulation, and function. Antioxid. Redox. Signal., 2006, 8, 1583-1596.
100. Green, S.P.; Cairns, B.; Rae, J.; Errett-Baroncini, C.; Hongo, J.A.; Erickson, R.W.; Curnutte, J.T. Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation. J. Cereb. Blood Flow Metab., 2001, 21, 374-384.
101. Sankarapandi, S.; Zweier, J.L.; Mukherjee, G.; Quinn, M.T.; Huso, D.L. Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. Arch. Biochem. Biophys., 1998, 353, 312-321.
102. Lavigne, M.C.; Malech, H.L.; Holland, S.M.; Leto, T.L. Genetic requirement of p47phox for superoxide production by murine microglia. FASEB J., 2001, 15, 285-287.
103. Zekry, D.; Epperson, T.K.; Krause, K.H. A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia? IUBMB Life, 2003, 55, 307-313.
104. Mead, E.L.; Mosley, A.; Eaton, S.; Dobson, L.; Heales, S.J.; Pocock, J.M. Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglialneuronal interactions. J. Neurochem., 2012, 121, 287-301.
105. Gao, H.M.; Hong, J.S. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol., 2008, 29, 357-365.
106. Hanisch, U.K.; Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci., 2007, 10, 1387-1394.
107. Block, M.L.; Zecca, L.; Hong, J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci., 2007, 8, 57-69.
108. Alford, S.; Grillner, S. CNQX and DNQX block non-NMDA synaptic transmission but not NMDA-evoked locomotion in lamprey spinal cord. Brain Res., 1990, 506, 297-302.
109. Balchen, T.; Diemer, N.H. The AMPA antagonist, NBQX, protects against ischemia-induced loss of cerebellar Purkinje cells. Neuroreport, 1992, 3, 785-788.
110. Suma, T.; Koshinaga, M.; Fukushima, M.; Kano, T.; Katayama, Y. Effects of in situ administration of excitatory amino acid antagonists on rapid microglial and astroglial reactions in rat hippocampus following traumatic brain injury. Neurol. Res., 2008, 30, 420-429.
111. Zhao, W.; Xie, W.; Le, W.; Beers, D.R.; He, Y.; Henkel, J.S.; Simpson, E.P.; Yen, A.A.; Xiao, Q.; Appel, S.H. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J. Neuropathol. Exp. Neurol., 2004, 63, 964-977.
112. Takahashi, J.L.; Giuliani, F.; Power, C.; Imai, Y.; Yong, V.W. Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann. Neurol., 2003, 53, 588-595.
113. Brison, E.; Jacomy, H.; Desforges, M.; Talbot, P.J. Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein. J. Virol., 2011, 85, 12464-12473.
114. Shibakawa, Y.S.; Sasaki, Y.; Goshima, Y.; Echigo, N.; Kamiya, Y.; Kurahashi, K.; Yamada, Y.; Andoh, T. Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide. Br. J. Anaesth., 2005, 95, 803-810.
115. Chang, Y.; Lee, J.J.; Hsieh, C.Y.; Hsiao, G.; Chou, D.S.; Sheu, J.R. Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation. Mediators Inflamm., 2009, 2009, 705379.
116. Kumar, S. Memantine: pharmacological properties and clinical uses. Neurol. India, 2004, 52, 307-309.
117. Rogawski, M.A. Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents--toward an understanding of their favorable tolerability. Amino Acids, 2000, 19, 133-149.
118. Chen, H.S.V.; Lipton, S.A. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem., 2006, 97, 1611-1626.
119. Wu, H.M.; Tzeng, N.S.; Qian, L.; Wei, S.J.; Hu, X.; Chen, S.H.; Rawls, S.M.; Flood, P.; Hong, J.S.; Lu, R.B. Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. Neuropsychopharmacology, 2009, 34, 2344-2357.
120. Takeda, K.; Muramatsu, M.; Chikuma, T.; Kato, T. Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain. J. Mol. Neurosci., 2009, 39, 380-390.
121. Rosi, S.; Vazdarjanova, A.; Ramirez-Amaya, V.; Worley, P.F.; Barnes, C.A.; Wenk, G.L. Memantine protects against LPSinduced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Neuroscience, 2006, 142, 1303-1315.
122. Howard, R.; McShane, R.; Lindesay, J.; Ritchie, C.; Baldwin, A.; Barber, R.; Burns, A.; Dening, T.; Findlay, D.; Holmes, C.; Hughes, A.; Jacoby, R.; Jones, R.; Jones, R.; McKeith, I.; Macharouthu, A.; O'Brien, J.; Passmore, P.; Sheehan, B.; Juszczak, E.; Katona, C.; Hills, R.; Knapp, M.; Ballard, C.; Brown, R.; Banerjee, S.; Onions, C.; Griffin, M.; Adams, J.; Gray, R.; Johnson, T.; Bentham, P.; Phillips, P. Donepezil and memantine for moderate-to-severe Alzheimer's disease. N. Engl. J. Med., 2012, 366, 893-903.
123. Reisberg, B.; Doody, R.; Stöffler, A.; Schmitt, F.; Ferris, S.; Möbius, H.J. Memantine Study Group Memantine in moderate-tosevere Alzheimer's disease. N. Engl. J. Med., 2003, 348, 1333-1341.
124. Domin, H.; Zie{ogonek}ba, B.; Gołembiowska, K.; Kowalska, M.; Dziubina, A.; Śmiałowska, M. Neuroprotective potential of mGluR5 antagonist MTEP: effects on kainate-induced excitotoxicity in the rat hippocampus. Pharmacol. Rep., 2010, 62(6), 1051-1061.
125. Movsesyan, V.A.; Faden, A.I. Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injury. J. Neurotrauma, 2006, 23(2), 117-127.